Medical Journals

Decrease in Endogenous Cgrp Release in Nitroglycerin Tolerance: Role of Aldh-2.

Authors:
  • Chen Yue-Rong
  • Nie Sheng-Dan
  • Shan Wang
  • Jiang De-Jian
  • Shi Rui-Zheng
  • Zhou Zhi
  • Guo Ren
  • Zhang Zhe
  • Li Yuan-Jian

From: Department of Pharmacology, School of Pharmaceautical Sciences, Central South University, Changsha 410078, China.

European journal of pharmacology

  • Publish Date: Sep 2007
  • ISSN: 0014-2999
  • Volume: 571
  • Issue: 1
  • Pages: 44-50
  • Medium: Print
  • Language: English
  • Citation (JAMA): Chen Yue-Rong, Nie Sheng-Dan, Shan Wang, et al. Decrease in Endogenous Cgrp Release in Nitroglycerin Tolerance: Role of Aldh-2.. Eur. J. Pharmacol. Sep 2007;571:44-50

Abstract

In the present study, we tested whether the decreased release of calcitonin gene-related peptide (CGRP) observed in nitroglycerin tolerance is associated with the decrease in aldehyde dehydrogenase (ALDH-2) activity. We further investigated the possible involvement of reactive oxygen species in the decrease in ALDH-2 activity. Tolerance was induced by exposure of isolated rat thoracic aortas and human umbical vein endothelial cells (HUVEC) to nitroglycerin in vitro or by pretreatment with nitroglycerin for 8 days in vivo. Pretreatment with ALDH-2 inhibitors and nitroglycerin significantly attenuated vasodilator responses to nitroglycerin concomitantly with a decrease in the release of CGRP from the isolated thoracic aorta. Nitroglycerin produced a depressor effect concomitantly with an increase in plasma concentrations of CGRP, and the effect of nitroglycerin was attenuated after pretreatment with an inhibitor of ALDH-2 or nitroglycerin for 8 days. Exposure of HUVEC to nitroglycerin for 16 h increased reactive oxygen species production and decreased ALDH-2 activity as well as cGMP production in a time-and concentration-dependent manner. Pretreatment with an ALDH-2 inhibitor also significantly decreased the cGMP production. However, tolerance to nitroglycerin in HUVEC was restored in the presence of N-acetylcysteine or captopril. The present results suggest that nitrate tolerance is, at least partially, associated with a decrease in endogenous CGRP release via a decrease in ALDH-2 activity as a result of stimulation of reactive oxygen species production.

Mesh Headings (Keywords): Acetylcysteine, Aldehyde Dehydrogenase, Angiotensin-Converting Enzyme Inhibitors, Animals, Aorta, Thoracic, Blood Pressure, Calcitonin Gene-Related Peptide, Captopril, Cell Line, Chloral Hydrate, Cyanamide, Cyclic GMP, Dose-Response Relationship, Drug, Drug Interactions, Drug Tolerance, Endothelial Cells, Humans, Male, Nitric Oxide Donors, Nitroglycerin, Rats, Rats, Wistar, Reactive Oxygen Species, Vasodilation


Check for Full Text / PubMed Unique Identifier (PMID): 17585900


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.